Yulian Xiao
Contributed to a study identifying a tRNA fragment (tRF-17-8SPOL52) that drives bortezomib resistance in multiple myeloma by activating autophagy
Hematology researcher · Third Xiangya Hospital, Central South University, China
Yulian Xiao is affiliated with the Department of Hematology at the Third Xiangya Hospital of Central South University. Yulian Xiao is a co-author, alongside lead author Fu Yunfeng, of work showing that the tRNA-derived fragment tRF-17-8SPOL52 suppresses the autophagy inhibitor RUBCN, boosts autophagic flux, and thereby helps multiple myeloma cells resist the proteasome inhibitor bortezomib.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | M | tRNA-derived fragment tRF-17-8SPOL52 induces resistance to bortezomib in multiple myeloma via autophagy activation. FU2026 Co-author on the myeloma study identifying the tRNA fragment tRF-17-8SPOL52 as an autophagy-driven mechanism of bortezomib resistance. |
Co-authors in the Atlas 1
People with a profile here who share at least one study with Yulian Xiao.
ShowHide
- Cong Xu Hematologist in Shenzhen who studies drug resistance and drug safety in multiple myeloma, and senior author of a study linking a small RNA fragment to autophagy-driven resistance to bortezomib
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.